Found 23 matching trials
Tenelia Triple Combination Study PHASE3 After a screening, a 2-week, single-blind placebo run-in, 200 patients will...
Show More Location
Samsung Medical Center
Learn More & Join Trial
IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics PHASE1 This is a Phase I, first-in-human, randomised, double-blinded, placebo-and ...
Show More Location
Parexel International GmbH Early Phase Clinical Unit Klinikum Westend
Learn More & Join Trial
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy PHASE4 To assess the efficacy of treatment with sitagliptin or dapagliflozin or lo...
Show More Learn More & Join Trial
CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) PHASE1 The purpose of this study is to evaluate a pharmacokinetic drug interaction...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial
A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes PHASE4 This is a randomized, open-label, active-controlled, parallel, multicenter,...
Show More Location
The Catholic University of Korea, Seoul St. Mary's Hospital
Learn More & Join Trial
MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus PHASE3 This Phase III clinical trial will examine the efficacy, safety, and tolera...
Show More Learn More & Join Trial
Effect of Sitagliptin on Progression of Coronary Intermediate Lesion PHASE4 This study was to investigate the Effect of Sitagliptin, a dipeptidyl pepti...
Show More Location
The General Hospital of PLA
Learn More & Join Trial
Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell NA Prevalence of diabetes is increasing rapidly both in China and all over the...
Show More Location
First Affiliated Hospital of Xi'an Jiao Tong University
Learn More & Join Trial
Sitagliptin for the Treatment of Type 2 Diabetes PHASE4 Patients newly diagnosed with T2D will be recruited and will receive sitagl...
Show More Location
Beijing Chao-Yang Hospital, Capital Medical University
Learn More & Join Trial
Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes PHASE4 This study was to investigate the Effect of Sitagliptin, a dipeptidyl pepti...
Show More Location
Multiple Locations
Learn More & Join Trial